ADVOCACY

Molecular diagnostics is a rapidly evolving field with frequently changing standards for care that challenge the current paradigm for coding, coverage and payment. In 2019, the Association for Molecular Pathology (AMP) brought together stakeholders from across the molecular diagnostics spectrum for a one-day summit aimed at improving the molecular diagnostics economic landscape. Following the success of this event, it was our intention to gather annually to discuss our rapidly evolving field and address how the current paradigm for coding, coverage, and payment must evolve to meet the changing standards of medical care.

The COVID-19 pandemic and its call to action for molecular professionals around the globe made this impossible in 2020. We are hopeful that 2021 will provide us with an opportunity to gather safely and continue the work we started with the first AMP Molecular Pathology Economics Summit.

Plans for this event are rapidly evolving and we will continually assess the feasibility of hosting this event in person. The safety of our participants is our number one concern.

We aim to harness the collective expertise of our community to advance the national dialogue toward improving patient access to appropriate molecular diagnostic care. Attendees will participate in guided discussions to identify barriers to appropriate reimbursement for molecular pathology procedures and then explore and have the opportunity to propose solutions to critical challenges that are limiting full realization of the possibilities offered by precision medicine. The Summit will connect experts across multiple industries and professional arenas harnessing the collective effort to advance the national dialogue towards improving patient access to appropriate molecular diagnostic care.

AMP’s Molecular Pathology Economics Summit will be a highly interactive one-day gathering focused on:

  • Identifying barriers to appropriate reimbursement for molecular pathology procedures;
  • Identifying the impact of these barriers on various stakeholders and patient access to care; and
  • Identifying potential solutions and/or novel approaches to overcoming barriers, with a goal of identifying shared policy agendas for the participating stakeholders in oncology, infectious diseases, and inherited conditions

Date: July 20, 2021
Time: 8:00am - 3:30pm Eastern
Location: The Conrad Washington D.C., 950 New York Ave NW, Washington, DC 20001

Registration: Registration will open on April 19, 2021

If you would like to be kept informed as more information becomes available, please contact us at policy@amp.org.


Program Chair & Facilitator

Program Chair
Samuel K. Caughron, MD
Chair, AMP Economic Affairs Committee
MAWD Pathology Group, P.A.
Bio

 

Program Facilitator
Amy M. Miller, PhD
President and CEO
Society for Women's Health Research
Bio

 


Agenda

Agenda for the 2021 AMP Molecular Pathology Economics Summit Coming Soon

You can view the agenda for the 2019 AMP Molecular Pathology Economics Summit here

 


Summit Planning Committee

AMP Economic Affairs Committee Vice Chair: Coverage Decisions
Pranil Chandra, DO
PathGroup, LLC

AMP Economic Affairs Committee Vice Chair: New Codes and Pricing
Jay Patel, MD
ARUP Laboratories

AMP Economic Affairs Committee Past-Vice Chair: New Codes and Pricing
Anthony Sireci, MD, MSc
Loxo Oncology

AMP Economic Affairs Committee Member
Tanner Hagelstrom, PhD, MBA
Illumina

AMP Economic Affairs Committee Member
Victoria Pratt, PhD
Indiana University Medical Center

AMP Economic Affairs Committee Junior Member
Salvatore Priore, MD, PhD
University of Pennsylvania
 


Registration Information

Information on registration will be coming soon!


Hotel & Travel Information

The 2021 AMP Molecular Pathology Economics Summit will be held at the Conrad Washington D.C. Hotel. 

Hotel registration information is coming soon. 

 

 


 

INDUSTRY PARTNERS

For more information on becoming an Industry Partner for this event please contact, Laurie Menser.

Corporate Partners